Imaging and interoperability solutions provider
Merge Healthcare Incorporated
) and Hyland Software Inc., a developer of enterprise content
management (ECM), extended their long-established partnership to
include an integrated comprehensive system for image viewing and
CONCEPTUS INC (CPTS): Free Stock Analysis
EDWARDS LIFESCI (EW): Free Stock Analysis
MERGE HEALTHCAR (MRGE): Free Stock Analysis
MYRIAD GENETICS (MYGN): Free Stock Analysis
To read this article on Zacks.com click here.
The integrated solution supplements Hyland's software suite -
OnBase for Health Information Management workflows, electronic
medical record (EMR) integration and Release of Information
capabilities. OnBase involves a wide range of clinical and
administrative workflow capabilities. The integrated solution by
Hyland and Merge Healthcare will provide access to diagnostic
data, both DICOM and non-DICOM, from any EMR on the back of
iConnect Access platform and OnBase.
Merge Healthcare's vendor neutral archive (VNA), dubbed iConnect
Enterprise Archive, will enable reciprocal operations in the
client organizations by avoiding imaging silos. This in turn will
minimize storage costs over the long haul and facilitate
connectivity to dissimilar systems.
The collective solution by Merge Healthcare and Hyland will
support the enterprise efforts to meet the Stage 2 criteria of
the Meaningful Use incentive program via image enablement of the
EMR. The combined solution will also enable client organizations
to reach HIMSS Stage 7 status of EMR adoption.
According to Merge Healthcare, its iConnect Enterprise Archive is
a VNA pioneer, overseeing and storing 37% of the global images.
The extended partnership with Hyland is expected to improve
workflow efficacy and image management for its customers.
Innovation has been an aggressive strategy for Merge Healthcare
to drive growth. Its undertaking to expand its portfolio to meet
the growing needs of a multi-billion dollar market is
encouraging. The company is also well placed to benefit from the
strong demand for EMR-related software in the foreseeable future
on the back of the Stimulus bill. As healthcare providers adopt
EMR, the demand for Merge Healthcare's solutions is expected to
We believe that innovation and contract wins for Merge Healthcare
will support growth amid a challenging reimbursement environment
and sluggish hospital spending in the U.S. With a consentient
upward revision in earnings estimate, the stock carries a Zacks
Rank #2 (Buy). Other Zacks Rank #2 medical stocks are